Advanced Oncotherapy (AVO)
22/10/2017 - 23:00 BRR Media
29/09/2017 - 06:37 StockMarketWire
Advanced Oncotherapy's operating losses rose to 7.3m in the six months to the end of June - up from 5.9m last time. Revenu...
29/09/2017 - 06:00 RNS
RNS Number: 1735S Advanced Oncotherapy PLC 29 September 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Half-year Report Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2017 and po...
04/09/2017 - 23:00 BRR Media
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment